Navigation Links
Ottawa researchers key to new neuromuscular disease care and research network
Date:6/13/2014

OTTAWA, June 12, 2014 The University of Calgary's Hotchkiss Brain Institute (HBI), the Canadian Institutes of Health Research (CIHR) and Muscular Dystrophy Canada have announced the launch of the Canadian Neuromuscular Disease Network. Four co-principal investigators in this national network are Ottawa-based: Dr. Bernard Jasmin, Dr. Rashmi Kothary, Dr. Jodi Warman and Dr. Hugh McMillan.

"The network is a critical initiative that will organize the efforts to improve clinical care and advance research in neuromuscular disease with expertise from around the country," says Dr. Bernard Jasmin, vice-dean research at the University of Ottawa Faculty of Medicine. "That almost half of the team's principal investigators are from Ottawa is a testament to the strength in neuromuscular research and neurosciences in this region."

Dr. Jasmin and Dr. Rashmi Kothary, deputy scientific director of the Ottawa Hospital Research Institute, are basic science researchers. Dr. Jodi Warman, a neurologist at the Ottawa Hospital and a neurogeneticist at the Children's Hospital of Eastern Ontario (CHEO), and Dr. Hugh McMillan, a child neurologist at CHEO, are both clinicians who carry out translational research and clinical trials.

The new network hopes to empower patients and families through improved access to needed information and resources, along with a patient portal to connect with each other. In addition, the network plans to enhance the delivery of clinical care, increase capacity and collaboration, and improve training opportunities for researchers and clinical care providers.

Neuromuscular diseases as a group include over 150 different conditions, including muscular dystrophies, multiple sclerosis, spinal muscular atrophy and amyotrophic lateral sclerosis (commonly known as Lou Gehrig's disease). These diseases result in weakness and physical disability due to damage to muscle and nerve tissue.

"While neuromuscular diseases are rare in individuals, they affect a group of many Canadians," says Dr. Lawrence Korngut, network chair, a researcher in the University of Calgary Department of Clinical Neurosciences and a member of the HBI. "Partnering with the patient community is the only way forward for developing and testing potential treatments. Enhanced collaboration between researchers and clinicians across the country will improve both the effectiveness of research investments and the translation of this research from bench to bedside."

The network is the product of a $575,613 CIHR Network Catalyst grant from the CIHR Institute of Musculoskeletal Health and Arthritis and a $155,820 contribution from Muscular Dystrophy Canada.


'/>"/>
Contact: Adrienne Vienneau
avienneau@cheo.on.ca
613-737-7600 x4144
Children's Hospital of Eastern Ontario Research Institute
Source:Eurekalert

Related medicine news :

1. Don’t Compromise Your Health, Ottawa Residents!
2. TEAL Ottawa Launches Skin Imperfection Treatments by Thermo LO
3. Paul McCartney Tickets: Paul McCartney Tickets in Kanata Ottawa at the Scotiabank Place Go on Sale on Friday, April 26th at 10:00 a.m. Local Time
4. Ottawa researcher named 2013 Champion of Genetics
5. Champion of Genetics funding to Ottawa researcher
6. 2013 Ottawa Consumer Choice Award Winners
7. The Royal Mental Health Center of Ottawa Releases a Complete Mobile Application Suite for Veterans Coping with Operational Stress Injuries
8. Heritage Woods of Ottawa Affordable Assisted Living to Host Craft and Bake Sale
9. Alcohol & Drug Rehab Ottawa Launches Program Aimed at Reducing Adolescent Marijuana Addiction
10. Ottawa researchers find new pathway connected to type 2 diabetes
11. Ottawa researcher receives international award for obesity research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading ... the fourth quarter and full year ended December 31, 2015 on Monday, February 29, ... webcast for the investment community following the release at 4:30 PM ET. Investors interested ...
(Date:2/10/2016)... Carefree, AZ (PRWEB) , ... February 10, 2016 , ... ... coach in new book , Pioneering book "Better with Age: The Ultimate Guide to ... neuroplasticity can improve memory. The book’s publication date is March 16, 2016. ...
(Date:2/10/2016)... MA (PRWEB) , ... February 10, 2016 , ... ... their revolutionary, biocompatible columns and accessories. These PEEK-lined stainless steel (PLS) columns combine ... provide a solution that ensures the integrity of biological samples while operating at ...
(Date:2/10/2016)... ... February 10, 2016 , ... The recreational use of marijuana has been ... still face a lot of restrictions as to where they can smoke pot. ... use” and that cannabis “may not be consumed openly or publicly.” , Given the ...
(Date:2/10/2016)... ... February 09, 2016 , ... ... Face and Body Specialists are delighted to welcome a new addition to their ... Face and Body Specialists as a nurse practitioner performing cosmetic procedures ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... Corporation ("Unilife" or "Company") (NASDAQ: UNIS ; ASX: UNS), ... its financial results for the second quarter of fiscal 2016 (three ... Financial Results for the Second Quarter of ... Revenue for the second quarter of fiscal 2016 was $4.5 ... Cash receipts from customers for the second quarter of fiscal 2016 ...
(Date:2/9/2016)... February 9, 2016 ... heute den Abschluss eines Kooperationsvertrags mit 10x ... Lösungen in den Bereichen Next-Generation-Sequencing (NGS), Single-Cell-Biology ... ; Frankfurt Prime Standard: QIA) gab heute ... für die Entwicklung und Förderung umfassender Lösungen ...
(Date:2/9/2016)... February 9, 2016 QGEN ... collaboration with 10x Genomics to develop and promote ... and bioinformatics. --> QGEN ; Frankfurt ... 10x Genomics to develop and promote comprehensive solutions ... --> QIAGEN N.V. (NASDAQ: QGEN ...
Breaking Medicine Technology: